The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma

Gokuladhas, 2016, Exploring the potential role of chemopreventive agent, hesperetin conjugated pegylated gold nanoparticles in diethylnitrosamine-induced hepatocellular carcinoma in male wistar albino rats, Indian J Clin Biochem, 31, 171, 10.1007/s12291-015-0520-2 Afonso, 2016, Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma, J Clin Med, 5, 1, 10.3390/jcm5030030 Yu, 2016, Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human Hepatocellular Carcinoma, Am J Cancer Res, 6, 690 Wang, 2015, The expression and potential clinical value of microRNA in hepatocellular carcinoma, J Clin Exp Med, 14, 27 Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 11, 5, 10.3322/caac.21254 Siegel, 2015, Cancer death rates in US congressional districts, CA Cancer J Clin, 65, 339, 10.3322/caac.21292 He, 2016, Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis, Clin Res Hepatol Gastroenterol, 16, 30026 Skipper, 2013, Cancer genomics: a panoramic view of cancer, Nat Rev Genet, 11, 750, 10.1038/nrg3602 Ghosh, 2016, Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected Hepatocellular Carcinoma, Int J Cancer, 138, 2732, 10.1002/ijc.29999 Garzon, 2009, MicroRNAs in cancer, Annu Rev Med, 60, 167, 10.1146/annurev.med.59.053006.104707 Saus, 2016, Long non-coding RNAs as potential novel prognostic biomarkers in colorectal cancer, Front Genet, 54, 1 Park, 2016, Time-course changes in the expression of miR-122,-155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats, J Vet Sci, 17, 45, 10.4142/jvs.2016.17.1.45 Okamoto, 2016, A series of microRNA in the chromosome 14q32.2 maternally impritnted region related to progression of non-alcoholic fatty liver disease in a mouse model, PLoS One, 11, 1, 10.1371/journal.pone.0154676 He, 2015, MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis, Clin Res Hepatol Gastroenterol, 39, 426, 10.1016/j.clinre.2015.01.006 Morishita, 2015, MicroRNAs in hepatocellular carcinoma, Hepatol Res, 45, 128, 10.1111/hepr.12386 Zhu, 2016, Epidemiology of hepatocellular carcinoma in the asia-pacific region, Gut Liver, 10, 331, 10.5009/gnl15257 Farinati, 2016, Development and validation of a new prognostic system for patients with hepatocellular carcinoma, PLos Med, 13, 1, 10.1371/journal.pmed.1002006 Qi, 2015, Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma, Int J Cancer, 136, 1835, 10.1002/ijc.29199 Zuo, 2015, MiR-210 links hypoxia with cell proliferation regulation in human laryngocarcinoma cancer, J Cell Biochem, 116, 1039, 10.1002/jcb.25059 Zhang, 2015, Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma, PLos One, 10, 1 Takahashi, 2014, Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human Hepatocellular Cancer, FEBS Open Bio, 21, 458, 10.1016/j.fob.2014.04.007 Blachier, 2013, The burden of liver disease in Europe: a review of available epidemiological data, J Hepatol, 58, 593, 10.1016/j.jhep.2012.12.005 Jelic, 2010, Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, AnnOncol, 21, 59 Liu, 2016, Giganteaside D induces ROS-mediated apoptosis in human Hepatocellular Carcinoma cells through the MAPK pathway, Cell Oncol, 6, 1 Yuen, 2000, Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience, Hepatology, 31, 330, 10.1002/hep.510310211 Fukuda, 2005, Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma, Hepatol Gastroenterol, 52, 1163 Bruix, 2014, Hepatocellular carcinoma: clinical frontiers and perspectives, Gut, 63, 844, 10.1136/gutjnl-2013-306627 Han, 2014, Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy, World J Gastroenterol, 20, 10249, 10.3748/wjg.v20.i30.10249 Liu, 2016, The prognostic value of alpha-fetoprotein response for advanced-stage hepatocellular carcinoma treated with sorafenib combined with transarterial chemoembolization, Sci Rep, 6, 1 Rapaccini, 2004, Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients, Liver Int, 24, 124, 10.1111/j.1478-3231.2004.0903.x Debruyne, 2008, Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications, Clin Chim Acta, 395, 19, 10.1016/j.cca.2008.05.010 Yao, 2016, The expression and significance of microRNA in primary hepatocellular carcinoma, Pract J Cancer, 31, 165 Songlin, 2015, Analysis of clinicopathological features and prognosis between alpha-fetoprotein negative and positive hepatocellular carcinoma patients after R0 radical hepatectomy, Chin J Oncol, 37, 308 Seleem, 2015, Laparoscopic assisted per-frequency ablation (Laprfa)as a new modality for treatment of HCC in cirrhotic liver, J Egypt Soc Parasitol, 45, 451 Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc Natl Acad Sci U. S. A, 108, 5003, 10.1073/pnas.1019055108 Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 13, 423, 10.1038/ncb2210 Wang, 2010, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucleic Acids Res, 38, 7248, 10.1093/nar/gkq601 Van Hees, 2016, Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma, World J Gastroenterol, 37, 8271, 10.3748/wjg.v22.i37.8271 Gilad, 2008, Serum microRNAs are promising novel biomarkers, PLoS One, 3, 3148.1, 10.1371/journal.pone.0003148 Kasinski, 2011, MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy, Nat Rev Cancer, 11, 849, 10.1038/nrc3166 Dykxhoor, 2010, MicroRNAs and metastasis: little RNAs go a long way, Cancer Res, 70, 6401, 10.1158/0008-5472.CAN-10-1346 Kong, 2012, microRNAs in cancer management, Lancet Oncol, 6, 249, 10.1016/S1470-2045(12)70073-6 Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634 Hua, 2015, MicroRNA-153 promotes Wnt/beta-catenin activation in hepatocellular carcinoma through suppression of WWOX, Oncotarget, 6, 3840, 10.18632/oncotarget.2927 Yan, 2015, MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN, Tumour Biol, 36, 4747, 10.1007/s13277-015-3124-9 Schutte, 2015, Current biomarkers for hepatocellular carcinoma: surveillance, diagnosis and prediction of prognosis, World J Hepatol, 7, 139, 10.4254/wjh.v7.i2.139 Kutay, 2006, Down-regulation of miR-122 in the rodent and human Hepatocellular Carcinoma, J Cell Biochem, 99, 671, 10.1002/jcb.20982 Diao, 2010, Protemic identification of microRNA-122a target proteins in Hepatocellular Carcinoma, Proteomics, 20, 3723, 10.1002/pmic.201000050 Chen, 2016, MicroRNA-630 suppresses tumor metastasis through the TGF-β-miR-630-Slug signaling pathway and correlates inversely with poor prognosis in Hepatocellular Carcinoma, Oncotarget, 25, 1 Chen, 2016, MicroRNA-379-5P inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in Hepatocellular Carcinoma, Cancer Lett, 375, 73, 10.1016/j.canlet.2016.02.043 Tomimaru, 2012, Circulating microRNA-21 as a novel biomarker for Hepatocellular Carcinoma, J Hepatal, 56, 167, 10.1016/j.jhep.2011.04.026 Liao, 2015, Potential role of circulating microRNA-21 for hepatocellular carcinoma diagnosis: A meta-analysis, PLoS One, 6, 1 Ding, 2015, Circulating microRNAs in patients with polycystic ovary syndrome, Hum Fertil (Camb), 18, 22, 10.3109/14647273.2014.956811 He, 2016, Altered plasma MicroRNAs as novel biomarkers for arteriosclerosis obliterans, J Atheroscler Thromb, 23, 196, 10.5551/jat.30775